[Convano] Medium-Term Management Strategy and Axellmark Consolidation Acquisition | May 2026

Performance Overview

On May 29, 2026, Convano concluded a third-party allotment of shares and a 30 billion yen facility agreement to acquire Axellmark as a consolidated subsidiary. The investment amount is 900 million yen, and at the time of achieving Axellmark's mid-term market capitalization target of 20 billion yen, an economic value of approximately 13.8 billion yen is expected to accrue. The impact on consolidated performance and shareholder return measures are also under development.

Future Outlook and Impact on Shareholders

This transaction is expected to expand Axellmark's market capitalization and contribute to performance growth. Post-acquisition, expansion of the healthcare business and active M&A are anticipated to create upside potential exceeding plans. Shareholder return policies will also be strengthened to maximize shareholder value rapidly.